This program is supported by Bayer Schering Pharma.

Faculty: Nasser Hanna, MD George Blumenschein, MD Ulrich Gatzemeier, MD

During this case-based meeting, leaders in the field discuss clinical issues encountered daily with participants in an interactive format.

Topics include:

• Introduction to the role of Novel Therapeutic Agents and Targets in Lung Cancer Treatment
• Multitargeted Kinase Inhibitors in NSCLC: Rationale and Early Clinical Development
• Optimizing Multitargeted Kinase Inhibition Strategies: Treatments on the Horizon
• Novel Approaches and Innovative Future Directions

Click here for more information